United States· US:0944-2512_2233ffe2-ff7d-44b6-b95b-fb985e25c758
HYQVIA
A medicinal product containing immune globulin infusion (human), 10% with recombinant human hyaluronidase, registered in United States by Takeda Pharmaceuticals America, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1109442512021 KIT in 1 CARTON (0944-2512-02) * 100 mL in 1 VIAL, GLASS (0944-2717-10) * 5 mL in 1 VIAL, GLASS (0944-2722-03)
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7377d1b-0799-4bb5-bd89-111377fd9126 GET /v1/drugs/f7377d1b-0799-4bb5-bd89-111377fd9126?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": null,
"spl_meta": {
"7ca2c26f-4be2-48cd-be5b-486e350654ba": {
"match": "brand_token",
"title": "HYQVIA (IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
"spl_version": "22",
"published_date": "2026-02-10"
}
},
"productid": "0944-2512_2233ffe2-ff7d-44b6-b95b-fb985e25c758",
"productndc": "0944-2512",
"dosage_form": "KIT",
"dea_schedule": null,
"product_type": "PLASMA DERIVATIVE",
"substance_name": null,
"proprietary_name": "HYQVIA",
"active_ingred_unit": null,
"application_number": "BLA125402",
"marketing_category": "BLA",
"nonproprietary_name": "Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase",
"start_marketing_date": "20140912",
"active_numerator_strength": null
}See everything about immune globulin infusion (human), 10% with recombinant human hyaluronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.